Comparison of biochemical failure definitions for predicting local cancer recurrence following cryoablation of the prostate

Prostate

Volumn 72, Issue 16, 2012, Pages 1802-1808

  Pitman, Max ^a   Shapiro, Edan Y ^a   Hruby, Gregory W ^a   Truesdale, Matthew D ^a   Cheetham, Philippa J ^a   Saad, Shumaila ^a   Katz, Aaron E ^b  

^a College of Physicians and Surgeons ^*  (United States)

^b WINTHROP UNIVERSITY HOSPITAL   (United States)

Author keywords

biological markers; cryosurgery; prostatic neoplasms

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

AGED; ARTICLE; CANCER RECURRENCE; CANCER STAGING; COMPARATIVE STUDY; CRYOABLATION; CRYOSURGERY; FOLLOW UP; GLEASON SCORE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; PROSTATE BIOPSY; PROSTATE CANCER; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; TRANSRECTAL ULTRASONOGRAPHY;

ADENOCARCINOMA; AGED; CRYOSURGERY; DATABASES, FACTUAL; HUMANS; MALE; NEOPLASM GRADING; NEOPLASM RECURRENCE, LOCAL; PREDICTIVE VALUE OF TESTS; PROSTATE; PROSTATIC NEOPLASMS; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 84867863478     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.22541     Document Type: Article

References (26)

1. Donnelly BJ, Saliken JC, Brasher PM, Ernst SD, Rewcastle JC, Lau H, Robinson J, Trpkov K,. A randomized trial of external beam radiotherapy versus cryoablation in patients with localized prostate cancer. Cancer 2010; 116 (2): 323-330.
2. Cheetham P, Truesdale M, Chaudhury S, Wenske S, Hruby GW, Katz A,. Long-term cancer-specific and overall survival for men followed more than 10 years after primary and salvage cryoablation of the prostate. J Endourol 2010; 24 (7): 1123-1129.
3. Roach M III, Hanks G, Thames H Jr, Schellhammer P, Shipley WU, Sokol GH, Sandler H,. Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: Recommendations of the RTOG-ASTRO Phoenix Consensus Conference. Int J Radiat Oncol Biol Phys 2006; 65 (4): 965-974.
4. American Society for Therapeutic Radiology and Oncology Consensus Panel. Consensus statement: Guidelines for PSA following radiation therapy. Int J Radiat Oncol Biol Phys 1997; 37 (5): 1035-1041.
5. Truesdale MD, Cheetham PJ, Hruby GW, Wenske S, Conforto AK, Cooper AB, Katz AE,. An evaluation of patient selection criteria on predicting progression-free survival after primary focal unilateral nerve-sparing cryoablation for prostate cancer: Recommendations for follow up. Cancer J 2010; 16 (5): 544-549.
6. Levy DA, Pisters LL, Jones JS,. Primary cryoablation nadir prostate specific antigen and biochemical failure. J Urol 2009; 182 (3): 931-937.
7. Pisters LL, Rewcastle JC, Donnelly BJ, Lugnani FM, Katz AE, Jones JS,. Salvage prostate cryoablation: Initial results from the cryo on-line data registry. J Urol 2008; 180 (2): 559-563; discussion 563-554.
8. Bahn DK, Silverman P, Lee F Sr, Badalament R, Bahn ED, Rewcastle JC,. Focal prostate cryoablation: Initial results show cancer control and potency preservation. J Endourol 2006; 20 (9): 688-692.
9. Dhar N, Ward JF, Cher ML, Jones JS,. Primary full-gland prostate cryoablation in older men (>age of 75 years): Results from 860 patients tracked with the COLD registry. BJU Int 2011; 108 (4): 508-512.
10. Edge SB,. American Joint Committee on Cancer. AJCC cancer staging manual, 7th ed. New York: Springer; 2010. xiv, 648 pp.
11. Metz CE,. Basic principles of ROC analysis. Semin Nucl Med 1978; 8 (4): 283-298.
12. Cooperberg MR, Lubeck DP, Meng MV, Mehta SS, Carroll PR,. The changing face of low-risk prostate cancer: Trends in clinical presentation and primary management. J Clin Oncol 2004; 22 (11): 2141-2149.
13. Pisters LL,. Cryotherapy for prostate cancer: Ready for prime time? Curr Opin Urol 2010; 20 (3): 218-222.
14. Eggener SE, Scardino PT, Carroll PR, Zelefsky MJ, Sartor O, Hricak H, Wheeler TM, Fine SW, Trachtenberg J, Rubin MA, Ohori M, Kuroiwa K, Rossignol M, Abenhaim L,. Focal therapy for localized prostate cancer: A critical appraisal of rationale and modalities. J Urol 2007; 178 (6): 2260-2267.
15. Bahn DK, Lee F, Badalament R, Kumar A, Greski J, Chernick M,. Targeted cryoablation of the prostate: 7-year outcomes in the primary treatment of prostate cancer. Urology 2002; 60 (2 Suppl. 1): 3-11.
16. Cohen JK, Miller RJ Jr, Ahmed S, Lotz MJ, Baust J,. Ten-year biochemical disease control for patients with prostate cancer treated with cryosurgery as primary therapy. Urology 2008; 71 (3): 515-518.
17. Jones JS, Rewcastle JC, Donnelly BJ, Lugnani FM, Pisters LL, Katz AE,. Whole gland primary prostate cryoablation: Initial results from the cryo on-line data registry. J Urol 2008; 180 (2): 554-558.
18. Ellis DS, Manny TB Jr, Rewcastle JC,. Focal cryosurgery followed by penile rehabilitation as primary treatment for localized prostate cancer: Initial results. Urology 2007; 70 (6 Suppl.): 9-15.
19. Lambert EH, Bolte K, Masson P, Katz AE,. Focal cryosurgery: Encouraging health outcomes for unifocal prostate cancer. Urology 2007; 69 (6): 1117-1120.
20. Onik G, Vaughan D, Lotenfoe R, Dineen M, Brady J,. The "male lumpectomy": Focal therapy for prostate cancer using cryoablation results in 48 patients with at least 2-year follow-up. Urol Oncol 2008; 26 (5): 500-505.
21. Caso JR, Tsivian M, Mouraviev V, Polascik TJ,. Predicting biopsy-proven prostate cancer recurrence following cryosurgery. Urol Oncol 2010; DOI: 10.1016/j.urolonc.2010.04.001.
22. Shinohara K, Rhee B, Presti JC Jr, Carroll PR,. Cryosurgical ablation of prostate cancer: Patterns of cancer recurrence. J Urol 1997; 158 (6): 2206-2209; discussion 2209-2210.
23. Levy DA, Jones JS,. Impact of prostate gland volume on cryoablation prostate-specific antigen outcomes. Urology 2011; 77 (4): 994-998.
24. Spiess PE, Katz AE, Chin JL, Bahn D, Cohen JK, Shinohara K, Hernandez M, Bossier J, Kassouf W, Pisters LL,. A pretreatment nomogram predicting biochemical failure after salvage cryotherapy for locally recurrent prostate cancer. BJU Int 2010; 106 (2): 194-198.
25. Zisman A, Pantuck AJ, Cohen JK, Belldegrun AS,. Prostate cryoablation using direct transperineal placement of ultrathin probes through a 17-gauge brachytherapy template-technique and preliminary results. Urology 2001; 58 (6): 988-993.
26. Horwitz EM, Thames HD, Kuban DA, Levy LB, Kupelian PA, Martinez AA, Michalski JM, Pisansky TM, Sandler HM, Shipley WU, Zelefsky MJ, Hanks GE, Zietman AL,. Definitions of biochemical failure that best predict clinical failure in patients with prostate cancer treated with external beam radiation alone: A multi-institutional pooled analysis. J Urol 2005; 173 (3): 797-802.